{{Rsnum
|rsid=11051970
|Chromosome=12
|position=32384554
|Orientation=plus
|GMAF=0.3691
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 57.4 | 29.6 | 13.0
| HCB | 38.1 | 45.2 | 16.7
| JPT | 18.2 | 54.5 | 27.3
| YRI | 50.0 | 45.0 | 5.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 38.1 | 45.2 | 16.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=0.000001
|OR=2.0800
|ORtxt=None
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}